A Canadian platform to study the antibody response to SARS-CoV-2 infection and vaccination

A group of Canadian researchers has developed a set of standardized, high-throughput serological assays to detect antibodies against SARS-CoV-2. Multiple studies estimating the seroprevalence of various populations in Canada – including over half of those funded by the CITF – use this platform, making it possible to harmonize and compare their results nationwide. In … Continue reading A Canadian platform to study the antibody response to SARS-CoV-2 infection and vaccination